vs
Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $60.1M, roughly 1.9× RHYTHM PHARMACEUTICALS, INC.). DULUTH HOLDINGS INC. runs the higher net margin — -8.8% vs -92.6%, a 83.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs -9.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs -31.6%).
Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
DLTH vs RYTM — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $114.9M | $60.1M |
| Net Profit | $-10.1M | $-55.6M |
| Gross Margin | 53.8% | 88.1% |
| Operating Margin | -7.7% | -87.1% |
| Net Margin | -8.8% | -92.6% |
| Revenue YoY | -9.6% | 83.8% |
| Net Profit YoY | 64.6% | — |
| EPS (diluted) | $-0.29 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $60.1M | ||
| Q4 25 | $114.9M | $57.3M | ||
| Q3 25 | $131.7M | $51.3M | ||
| Q2 25 | $102.7M | $48.5M | ||
| Q1 25 | $241.3M | $32.7M | ||
| Q4 24 | $127.1M | $41.8M | ||
| Q3 24 | $141.6M | $33.3M | ||
| Q2 24 | $116.7M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $-10.1M | $-47.5M | ||
| Q3 25 | $1.3M | $-52.9M | ||
| Q2 25 | $-15.3M | $-46.6M | ||
| Q1 25 | $-5.6M | $-49.5M | ||
| Q4 24 | $-28.2M | $-43.3M | ||
| Q3 24 | $-2.0M | $-43.6M | ||
| Q2 24 | $-7.9M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | 53.8% | 91.6% | ||
| Q3 25 | 54.7% | 89.3% | ||
| Q2 25 | 52.0% | 88.6% | ||
| Q1 25 | 44.1% | 88.8% | ||
| Q4 24 | 52.3% | 90.9% | ||
| Q3 24 | 52.3% | 88.5% | ||
| Q2 24 | 52.8% | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | -7.7% | -82.2% | ||
| Q3 25 | 1.8% | -102.6% | ||
| Q2 25 | -12.0% | -93.4% | ||
| Q1 25 | -1.8% | -143.7% | ||
| Q4 24 | -17.4% | -98.6% | ||
| Q3 24 | -1.1% | -132.0% | ||
| Q2 24 | -7.7% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | -8.8% | -83.0% | ||
| Q3 25 | 1.0% | -103.1% | ||
| Q2 25 | -14.9% | -96.1% | ||
| Q1 25 | -2.3% | -151.4% | ||
| Q4 24 | -22.2% | -103.6% | ||
| Q3 24 | -1.4% | -131.2% | ||
| Q2 24 | -6.7% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-0.29 | $-0.73 | ||
| Q3 25 | $0.04 | $-0.82 | ||
| Q2 25 | $-0.45 | $-0.75 | ||
| Q1 25 | $-0.17 | $-0.81 | ||
| Q4 24 | $-0.84 | $-0.71 | ||
| Q3 24 | $-0.06 | $-0.73 | ||
| Q2 24 | $-0.24 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.2M | $340.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $160.6M | $122.9M |
| Total Assets | $468.0M | $442.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | $8.2M | $388.9M | ||
| Q3 25 | $5.7M | $416.1M | ||
| Q2 25 | $8.6M | $291.0M | ||
| Q1 25 | $3.3M | $314.5M | ||
| Q4 24 | $9.3M | $320.6M | ||
| Q3 24 | $9.8M | $298.4M | ||
| Q2 24 | $6.8M | $319.1M |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $160.6M | $139.1M | ||
| Q3 25 | $170.0M | $148.8M | ||
| Q2 25 | $167.9M | $-11.9M | ||
| Q1 25 | $182.7M | $18.9M | ||
| Q4 24 | $188.1M | $21.7M | ||
| Q3 24 | $215.7M | $11.2M | ||
| Q2 24 | $218.4M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $468.0M | $480.2M | ||
| Q3 25 | $433.8M | $506.9M | ||
| Q2 25 | $463.7M | $372.7M | ||
| Q1 25 | $452.4M | $386.7M | ||
| Q4 24 | $533.1M | $392.3M | ||
| Q3 24 | $488.6M | $363.6M | ||
| Q2 24 | $471.4M | $381.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.7M | — |
| Free Cash FlowOCF − Capex | $-8.9M | — |
| FCF MarginFCF / Revenue | -7.8% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-6.7M | $-25.4M | ||
| Q3 25 | $32.0M | $-26.6M | ||
| Q2 25 | $-56.5M | $-23.3M | ||
| Q1 25 | $41.2M | $-40.4M | ||
| Q4 24 | $-41.1M | $-18.8M | ||
| Q3 24 | $16.6M | $-25.2M | ||
| Q2 24 | $-33.7M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $-57.8M | — | ||
| Q1 25 | $38.7M | — | ||
| Q4 24 | $-43.7M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $-35.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -7.8% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | -56.3% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | -34.4% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | -30.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.40× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
RYTM
Segment breakdown not available.
